Department of Surgery and Transplantation, University Hospital Zurich, Zurich, Switzerland.
Department of Nephrology, University Hospital Zurich, Zurich, Switzerland.
Clin Transplant. 2021 Mar;35(3):e14197. doi: 10.1111/ctr.14197. Epub 2020 Dec 29.
Obesity adversely affects wait-listing and precludes patients with concomitant end-stage renal disease and type 1 diabetes mellitus from getting a simultaneous pancreas and kidney transplantation (SPK).
To analyze safety and efficacy of laparoscopic sleeve gastrectomy (LSG) before SPK in severely obese type I diabetics.
We assessed weight curve, complications, and graft function of three patients who underwent LSG before SPK.
LSG was uneventful in all patients. Body mass index dropped from 38.4 (range 35.7 - 39.9) before LSG to 28.5 (26.8 - 30.9) until SPK, with a mean loss of 25.8% (22.4 - 32.3). Interval between LSG and SPK was 364.3 (173 - 587) days. Pancreas and kidney graft function was excellent, with 100% insulin-free and dialysis-free survival over a mean follow-up of 3.6 (2.9 - 4.5) years. A1C dropped from 7% (6.3 - 8.2) before LSG to 4.9% (4.7 - 5.3) and 4.8% (4.5 - 5.1) 1 and 2 years after SPK, respectively.
LSG before SPK is safe and effective to enable severely obese type I diabetics to receive a lifesaving transplant. This is the first study analyzing the role of bariatric surgery before simultaneous pancreas and kidney transplantation.
肥胖对等候名单有不利影响,并使同时患有终末期肾病和 1 型糖尿病的患者无法同时进行胰腺和肾脏移植(SPK)。
分析腹腔镜袖状胃切除术(LSG)在严重肥胖 1 型糖尿病患者 SPK 前的安全性和有效性。
我们评估了 3 例接受 SPK 前 LSG 的患者的体重曲线、并发症和移植物功能。
所有患者的 LSG 均无并发症。体重指数从 LSG 前的 38.4(范围 35.7-39.9)降至 SPK 时的 28.5(26.8-30.9),平均下降 25.8%(22.4-32.3)。LSG 和 SPK 之间的间隔为 364.3(173-587)天。胰腺和肾脏移植物功能良好,胰岛素和透析均无需 100%存活,平均随访 3.6(2.9-4.5)年后。A1C 从 LSG 前的 7%(6.3-8.2)降至 SPK 后 1 年的 4.9%(4.7-5.3)和 2 年的 4.8%(4.5-5.1)。
SPK 前的 LSG 安全有效,可使严重肥胖的 1 型糖尿病患者接受挽救生命的移植。这是第一项分析减肥手术在胰腺和肾脏同时移植前作用的研究。